Pre-order Enquiry
Request Free Sample
Global Anti-Infective Ophthalmic Market Research Report 2022
SKU ID : QYR-21040943 | Publishing Date : 08-Jun-2022
Request Sample
Request Customization
Check Discounts
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
Due to the COVID-19 pandemic, the global Anti-Infective Ophthalmic market size is estimated to be worth US$ 1468.1 million in 2021 and is forecast to a readjusted size of US$ 1849.8 million by 2028 with a CAGR of 3.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Anti-Infective Ophthalmic market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Anti-Infective Ophthalmic landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
This report focuses on Anti-Infective Ophthalmic volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Anti-Infective Ophthalmic market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Global Anti-Infective Ophthalmic Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others
Segment by Application
Hospital
Clinic
Household
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis
Allergan
Valeant Pharmaceuticals
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Due to the COVID-19 pandemic, the global Anti-Infective Ophthalmic market size is estimated to be worth US$ 1468.1 million in 2021 and is forecast to a readjusted size of US$ 1849.8 million by 2028 with a CAGR of 3.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Anti-Infective Ophthalmic market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Anti-Infective Ophthalmic landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
This report focuses on Anti-Infective Ophthalmic volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Anti-Infective Ophthalmic market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.
Global Anti-Infective Ophthalmic Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others
Segment by Application
Hospital
Clinic
Household
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Novartis
Allergan
Valeant Pharmaceuticals
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
